Waters Co. (NYSE:WAT) Shares Sold by Hutchinson Capital Management CA

Hutchinson Capital Management CA lowered its position in shares of Waters Co. (NYSE:WAT) by 0.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 49,826 shares of the medical instruments supplier’s stock after selling 143 shares during the quarter. Waters accounts for 3.5% of Hutchinson Capital Management CA’s holdings, making the stock its 8th biggest position. Hutchinson Capital Management CA’s holdings in Waters were worth $18,484,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Bank of Jackson Hole Trust acquired a new position in Waters during the 4th quarter worth approximately $34,000. Fortitude Family Office LLC boosted its position in Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 66 shares during the last quarter. Steward Partners Investment Advisory LLC boosted its position in Waters by 129.3% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier’s stock worth $35,000 after acquiring an additional 53 shares during the last quarter. EverSource Wealth Advisors LLC boosted its position in Waters by 54.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier’s stock worth $46,000 after acquiring an additional 44 shares during the last quarter. Finally, R Squared Ltd bought a new stake in shares of Waters during the 4th quarter worth approximately $63,000. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Stock Up 3.8 %

WAT stock opened at $378.18 on Friday. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The stock has a market capitalization of $22.47 billion, a price-to-earnings ratio of 35.31, a PEG ratio of 3.79 and a beta of 1.00. The business’s fifty day moving average price is $391.24 and its two-hundred day moving average price is $370.28. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56.

Waters (NYSE:WAT) last posted its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, equities analysts anticipate that Waters Co. will post 12.86 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on WAT shares. Scotiabank upgraded Waters from a “sector perform” rating to a “sector outperform” rating and upped their price objective for the stock from $430.00 to $450.00 in a research note on Thursday, February 13th. StockNews.com cut Waters from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. Bank of America dropped their price objective on Waters from $430.00 to $410.00 and set a “neutral” rating on the stock in a research note on Thursday, February 13th. JPMorgan Chase & Co. upped their price objective on Waters from $380.00 to $390.00 and gave the stock a “neutral” rating in a research note on Thursday, March 6th. Finally, Barclays upgraded Waters from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $360.00 to $415.00 in a research note on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $391.07.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.